fda glp 1 regulations 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale compounding of GLP-1 medications like semaglutide and tirzepatide, signaling a major shift in how these 21 CFR 11, 58, 820

Catch up quick: Compounders are allowed to make prescription drugs during shortages

Understanding how these medications affect the digestive system is essential for both clinicians and patients, as it provides context for managing potential side effects while maximizing therapeutic benefits for diabetes control and weight management

It triggers glucose-dependent insulin secretion from pancreatic beta cells, suppresses glucagon from alpha cells, slows gastric emptying, and signals satiety in the hypothalamus

Liver disease in heart failure with preserved ejection fraction The relationship between heart failure (HF) and liver disease is characterized by bidirectional interactions where one condition exacerbates the other

These methods work differently in the body and can have benefits and risks